THERAPEUTIC COMPOUNDS AND FORMULATIONS FOR INTRANASAL DELIVERY
Certain embodiments of the invention provide a formulation suitable for nasal administration comprising water, a prodrug of a therapeutic agent, and an enzyme that is suitable for intranasal conversion of the prodrug to the therapeutic agent, as well as methods of use thereof.
-
(2016/10/24)
More Articles about upstream products of 29176-44-1